Evidence map›Paper›PMID 42897463›Full record

ArticleBMC medical research methodology2026

A pragmatic workflow for handling missing PROM data in registry studies: a methodological scoping review and simulated worked example.

Johan Eriksson

Abstract readScoping Review
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Johan ErikssonDepartment of Diagnostics and Intervention/Surgery, Umeå University, Umeå, Sweden. johan.e.eriksson@umu.se.ORCID http://orcid.org/0000-0002-4653-2067

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient-reported outcome measures (PROMs) are increasingly integrated into clinical quality registries. Registry-based PROM data frequently exhibit structural non-response, including patients who never return PROMs ("never-responders"), and longitudinal attrition, making missing-not-at-random (MNAR) mechanisms plausible. Although MNAR sensitivity methods such as delta adjustment and tipping-point analysis are methodologically well-described, their uptake in registry-PROM practice is unknown.

methodsA structured search of PubMed (Nordic-specific terms), PubMed (global terms), Embase and CINAHL was conducted (2018-2024), yielding 425 records. After deduplication and screening, 61 registry-based observational PROM studies with explicit missing-data methods discussion were included as the primary analytic sample (17 Nordic, 44 global). The audit was conducted as a methodological scoping review and reported in accordance with the PRISMA extension for scoping reviews (PRISMA-ScR). A three-step pragmatic workflow is proposed and demonstrated: (1) non-response diagnostics separating never-responders from dropout, with standardized mean differences (SMD); (2) inverse probability weighting (IPW) as a default primary analysis strategy; and (3) MNAR sensitivity via delta adjustment with explicit tipping-point identification and a simple robustness classification. The workflow is demonstrated in a simulated registry-like cohort (N = 8,000).

resultsIn the primary analytic sample (n = 61), 24 studies (39%) stated no missing-data strategy. MNAR sensitivity analysis was reported in 18/61 (30%), but formal MNAR models were used in only 5/61 (8%). Critically, tipping-point analysis was not reported in any of the 61 included studies (0%); delta adjustment was reported in only 1/61 (2%). Never-responders were distinguished from dropout in only 17/61 (28%). In the simulated cohort, non-response was substantial and selective. In the primary scenario, the complete-case estimate was 1.21 PROM points (95% CI: 0.69-1.72), the single-stage IPW estimate was 1.22 (95% CI: 0.69-1.74), and the two-stage IPW estimate was 1.23 (95% CI: 0.67-1.79). The tipping point was δ* = 7.2 points (classified as sensitive under the illustrative thresholds). In the secondary scenario, the corresponding tipping point was δ* = 30.5 points (classified as stable).

conclusionsTipping-point analysis was not reported in the accessible methods or supplementary material of any of the 61 included registry-PROM studies; delta adjustment was reported in only one study as a sensitivity check. The five formal MNAR analyses identified used methods that typically require specialist expertise and stronger modeling assumptions than are routinely feasible in many registry settings. A pragmatic workflow using IPW and tipping-point analysis can close this gap without specialist infrastructure.

Indexed as

Patient Reported Outcome MeasuresRegistriesWorkflowHumansObservational Studies as TopicResearch DesignDelta adjustmentInverse probability weightingMissing dataMNARNon-responsePROMRegistriesSensitivity analysisTipping point

Identifiers

PMID42897463
PMCPMC13682039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.